लेटरमोविर

लेटरमोविर (917389-32-3)

Letermovir acts as an orally or i.v administered cytomegalovirus terminus complex inhibitor, antiviral agent, used in the treatment of CMV infection which is prevalent in those with immunocompromised systems. Product Name: Letermovir CAS No.: 917389-32-3 Assay: 99% Specification: CP, EP, In-house, as required Molecular Formula: C29H28F4N4O4 Molecular Weight: 572.55 Shelf Life: 2 Years Package: 25kg/drum